Welcome to our dedicated page for SEMPRA SEC filings (Ticker: SREA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on SEMPRA's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into SEMPRA's regulatory disclosures and financial reporting.
Form 144 notice for Sempra (symbol: SREA) shows a proposed sale of 28,864 shares of common stock through Oppenheimer & Co., with an aggregate market value of $2,422,844.16 and an approximate sale date of 09/15/2025. The filing reports that all shares to be sold were acquired primarily through vesting of restricted stock units and reinvested dividends under Sempra's Long-Term Incentive Plan, with acquisition dates ranging from 01/03/2022 through 02/19/2025. The filing lists 652,472,426 shares outstanding, and discloses that there were no securities sold by the filer in the past three months.